BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11829379)

  • 1. Developing a cancer genetics service in Wales: opinions of gynaecologists on the management of women at risk of familial ovarian cancer.
    Leeson S; Iredale R; Stansfield K; Evans A; Gray J
    Eur J Cancer Care (Engl); 2001 Sep; 10(3):172-8. PubMed ID: 11829379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Referral patterns for gynaecologic cancers and precancerous conditions.
    Gagliardi A; DePetrillo D; Elit L
    J Obstet Gynaecol Can; 2002 Jul; 24(7):553-8. PubMed ID: 12196846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. General practitioner referral patterns for women with gynaecological symptoms: a randomised incomplete block study design.
    Ramanathan SA; Baratiny G; Stocks NP; Searles AM; Redford RJ
    Med J Aust; 2011 Nov; 195(10):602-6. PubMed ID: 22107011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gynaecologists' abortion practice.
    Francome C; Savage WD
    Br J Obstet Gynaecol; 1992 Feb; 99(2):153-7. PubMed ID: 1554669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast and ovarian cancer referrals to the ACT Genetic Service: are we meeting guidelines?
    Aitken L; Warwick L; Davis A
    Intern Med J; 2017 Mar; 47(3):311-317. PubMed ID: 28019080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of GP referrals to a family cancer clinic for breast/ovarian cancer.
    Watson E; Austoker J; Lucassen A
    Fam Pract; 2001 Apr; 18(2):131-4. PubMed ID: 11264261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attitudes and knowledge of medical practitioners to hereditary cancer clinics and cancer genetic testing.
    Teng I; Spigelman A
    Fam Cancer; 2014 Jun; 13(2):311-24. PubMed ID: 24306515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health care professionals' attitudes towards population-based genetic testing and risk-stratification for ovarian cancer: a cross-sectional survey.
    Hann KEJ; Fraser L; Side L; Gessler S; Waller J; Sanderson SC; Freeman M; Jacobs I; Lanceley A;
    BMC Womens Health; 2017 Dec; 17(1):132. PubMed ID: 29246147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline BRCA1/2 testing practices in ovarian cancer: Current state and opportunities for new directions.
    Lheureux S; Karakasis K; Harter P; Scott C; Bacon M; Bryce J; Le Fur N; Pujade-Lauraine E; Oza AM
    Gynecol Oncol; 2016 Jan; 140(1):90-4. PubMed ID: 26475959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of patient reports on the referral process to two NSW cancer genetic services.
    Butel-Simoes GI; Spigelman AD
    Fam Cancer; 2014 Sep; 13(3):333-43. PubMed ID: 24648127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual provision or duplication? A survey of family planning provision.
    Singleton CD; Reuter S
    Br J Fam Plann; 1999 Jul; 25(2):41-4. PubMed ID: 10454653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mainstreaming cancer genetics: A model integrating germline BRCA testing into routine ovarian cancer clinics.
    Kentwell M; Dow E; Antill Y; Wrede CD; McNally O; Higgs E; Hamilton A; Ananda S; Lindeman GJ; Scott CL
    Gynecol Oncol; 2017 Apr; 145(1):130-136. PubMed ID: 28162234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: Randomized trial of a specialist genetic assessment service for familial breast cancer.
    Julian-Reynier C; Eisinger F; Moatti JP; Sobol H
    J Natl Cancer Inst; 2001 Jan; 93(2):158-9. PubMed ID: 11208894
    [No Abstract]   [Full Text] [Related]  

  • 14. Dental screening and referral of young children by pediatric primary care providers.
    dela Cruz GG; Rozier RG; Slade G
    Pediatrics; 2004 Nov; 114(5):e642-52. PubMed ID: 15520094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic counseling referral for ovarian cancer patients: a call to action.
    Garcia C; Harrison K; Ring KL; Sullivan MW; Rauh LA; Modesitt SC
    Fam Cancer; 2019 Jul; 18(3):303-309. PubMed ID: 30993488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence of Primary Care Physicians to Evidence-Based Recommendations to Reduce Ovarian Cancer Mortality.
    Stewart SL; Townsend JS; Puckett MC; Rim SH
    J Womens Health (Larchmt); 2016 Mar; 25(3):235-41. PubMed ID: 26978124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Referral of patients with a family history of breast/ovarian cancer--GPs' knowledge and expectations.
    Rose PW; Watson E; Yudkin P; Emery J; Murphy M; Fuller A; Lucassen A
    Fam Pract; 2001 Oct; 18(5):487-90. PubMed ID: 11604368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactions of GPs to a triage-controlled referral system for cancer genetics.
    Elwyn G; Iredale R; Gray J
    Fam Pract; 2002 Feb; 19(1):65-71. PubMed ID: 11818352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival in ovarian cancer in Wales: Prior to introduction of all Wales guidelines.
    Shylasree TS; Howells RE; Lim K; Jones PW; Fiander A; Adams M; Evans AS;
    Int J Gynecol Cancer; 2006; 16(5):1770-6. PubMed ID: 17009970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.